⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Bone Marrow Adiposity and Osteoblast–Adipocyte Fate
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-01 — Interferon Regulatory Factor 1 Inhibits the Adipogenic Differentiation of BMSCs via the AMPK-mTOR Signaling Axis and Induces Their Autophagy to Alleviate Osteoporosis-Related Bone Marrow Adiposity.: cross-connection with mtor-nutrient-sensing: IRF1 engagement of the AMPK–mTOR axis in BMSCs mechanistically links nutrient-sensing control to the osteoblast–adipocyte fate switch that drives age-related marrow adiposity. (novelty: 3)
- 2026-10-02 — Regional variation in vertebral bone marrow adiposity: a population-based atlas of age- and sex-specific patterns.: cross-connection with bone-marrow-adipose-tissue: Normative UK Biobank vertebral BMAT atlas provides population-scale spatial reference for the osteoblast–adipocyte fate-shift biology, grounding the mechanism in human regional baselines. (novelty: 3)
- 2026-09-15 — Reprogramming the Aging Type H Vascular Niche via Myeloid Angiogenic Cell-Derived Extracellular Vesicles: Mechanisms, Engineering Strategies, and Translational Perspectives.: cross-connection with vascular-aging: Type H vessel decline is proposed as a vascular-aging input feeding the osteoblast–adipocyte fate imbalance and marrow adiposity phenotype of the aging skeleton. (novelty: 3)
- 2026-09-22 — Not just fillers: the emerging role of bone marrow adipocytes in bone and bone marrow homeostasis.: cross-connection with bone-marrow-adipose-tissue: BMAT synthesis reinforces the osteoblast–adipocyte fate-switch framing, with MR evidence supporting a causal marrow-adiposity-to-osteoporosis link in humans. (novelty: 3)
Open questions
Related
Contributing findings
Potential Role for the Ubiquitin Ligase SIAH2 in Modulating Bone Morphology and Adiposity.
11-sep-2026
novelty 2
per-area 2
introduces